Publication | Closed Access
Palliative treatment of painful disseminated bone metastases with 186Rhenium-HEDP in patients with lung cancer.
14
Citations
0
References
2004
Year
The application of a standard dose of (186)Re-HEDP in patients with lung cancer and painful disseminated bone metastases has a satisfactory pain alleviating effect. The easy application and very low myelotoxicity are important factors in this group of patients. A better analgesic effect of the (186)Re-HEDP application can be expected if combined estimation of the (99m)Tc-MDP bone scan and the CT scan is used.